ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,792Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 223

$552K Total Retail Price of All Prescriptions

Rank: 52 out of 223

405 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 405 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 405 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

0% of this provider’s 10,264 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
SYNTHROID 529 509 1 35
HYDROCODONE-ACETAMINOPHEN 423 389 S3 2 5
OMEPRAZOLE 417 383 3 3
PRAVASTATIN SODIUM 410 380 4 15
ATORVASTATIN CALCIUM 373 348 5 17
AMLODIPINE BESYLATE 332 330 6 6
METFORMIN HCL ER 309 307 7 41
METOPROLOL SUCCINATE 295 289 8 20
ALENDRONATE SODIUM 275 270 9 19
CITALOPRAM HBR 257 252 10 16
ZOLPIDEM TARTRATE 255 243 11 8
BENAZEPRIL HCL 244 240 12 57
WARFARIN SODIUM 243 230 13 11
FUROSEMIDE 218 206 14 9
LOSARTAN POTASSIUM 173 169 15 14
GABAPENTIN 165 138 16 10
GALANTAMINE HBR 165 165 16 170
TRAMADOL HCL 162 150 18 18
POTASSIUM CHLORIDE 156 156 19 12
SIMVASTATIN 154 153 20 1
LISINOPRIL 154 134 20 4
RAMIPRIL 152 152 22 86
NAMENDA 146 146 23 48
BUPROPION XL 138 138 24 117
TAMSULOSIN HCL 129 128 25 26
CRESTOR 123 118 26 37
CARVEDILOL 111 111 27 23
VESICARE 103 103 28 169
SPIRONOLACTONE 100 100 29 55
TRAZODONE HCL 95 89 30 22
IRBESARTAN 95 93 30 200
PRAMIPEXOLE DIHYDROCHLORIDE 94 94 32 77
GLIMEPIRIDE 93 93 33 30
FINASTERIDE 90 89 34 58
HYDROCHLOROTHIAZIDE 89 74 35 13
LANTUS 89 74 35 34
BENAZEPRIL-HYDROCHLOROTHIAZIDE 87 87 37 135
PROAIR HFA 78 75 38 64
FLUTICASONE PROPIONATE 77 77 39 27
TORSEMIDE 70 70 40 98
SPIRIVA 68 57 41 82
CLOPIDOGREL 65 64 42 56
AMIODARONE HCL 64 64 43 148
ESCITALOPRAM OXALATE 63 51 44 104
PREDNISONE 62 60 45 43
LEVOTHYROXINE SODIUM 62 62 45 2
ALLOPURINOL 61 61 47 28
RANITIDINE HCL 61 36 47 65
PANTOPRAZOLE SODIUM 60 42 49 45
SERTRALINE HCL 59 55 50 21
FENOFIBRATE 57 53 51 38
PLAVIX 55 55 52 85
LANTUS SOLOSTAR 53 53 53 74
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 52 53 29
ACTOS 51 51 55 95
DIOVAN 50 50 56 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.